Stock Analiz

Cerence Inc. CRNC

Computer Software: Prepackaged Software · data as of November 13, 2026

$7.92Market cap $358M
Open the interactive analysis →

Cerence Inc. (CRNC) is a technology company listed in the US with a market value of about $358M. In the twelve months to June 30, 2026 it had revenue of $309M and net income of -$15M, a net margin of -5.0%.

Its overall Stock Analiz score is 1.0 out of 5 (weak). The strongest part is future growth (2/5); the weakest is track record (0/5).

Key numbers: a price to free cash flow of 4.6, 5-year revenue growth of -5% a year, a 5-year average ROIC of -24%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 80% below the current price.

About Cerence

Cerence is listed in the US and classified in computer software: prepackaged software. Revenue went from $277M in 2018 to $252M in 2025, a decline of about 1.4% a year. It was profitable in 3 of the last 8 years in our data. Its share count rose by 10% over three years (dilution for shareholders). It spends 39% of revenue on research and development.

Score: 1.0 / 5

Value1/5
Future growth2/5
Track record0/5
Financial health2/5
Shareholder returns0/5

Checks passed

  • P/FCF below 20
  • Profit margin improving
  • Strong R&D investment or growth above 20%
  • Positive free cash flow
  • Debt below 3 years of free cash flow

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • 3-year free cash flow growth above 10% a year
  • 5-year EPS growth above 10% a year

Valuation

P/E (TTM)—
Forward P/E10.5
P/FCF4.6
P/S1.2
P/B2.2
EV/EBITDA12.4
PEG—
Dividend yield0.00%
FCF yield21.9%
Shareholder yield0.7%
Intrinsic value vs. price−80%

Growth and quality

Revenue growth (1 yr)-24.1%
Revenue growth (5 yrs, per year)-5.3%
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-57.4%
ROIC (5-yr avg.)-23.6%
Profitable years (of last 10)3
Years paying a dividend—

Financials, last 8 years

Fiscal yearTTM20252024202320222021202020192018
Revenue$309M$252M$332M$294M$328M$387M$331M$303M$277M
Net income-$15M-$19M-$588M-$56M-$311M$46M-$18M$100M$6M
Free cash flow$79M$47M$12M$2M-$20M$62M$26M$84M$109M
EPS (diluted)$-0.36$-0.43$-14.12$-1.40$-7.93$1.17$-0.50$2.76$0.16
Net margin-5.0%-7.4%-177.4%-19.1%-94.8%11.8%-5.5%33.1%2.1%
ROIC—-0.5%-105.0%-2.2%-14.6%4.4%1.4%0.8%2.9%

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

What analysts expect

The average 12-month price target from 4 analysts is $10.75, 36% above the current price; targets range from $9.00 to $12.00; the consensus rating is “none”; expected EPS is $0.73 for the fiscal year ending September 30, 2026.

Frequently asked questions

Is Cerence stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 80% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does Cerence pay a dividend?

Not currently.

Is Cerence a good stock to buy?

We do not give buy or sell advice. Cerence scores 1.0 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.